a browser and database of cell-free DNA fragmentation patterns
Eduardo- 0
FinaleDB: a browser and database of cell-free DNA fragmentation patterns
Abstract: Circulating cell-free DNA (cfDNA) is a promising biomarker for the prognosis and prognosis of many ailments, together with most cancers. The genome-wide non-random fragmentation patterns of cfDNA are related to the nucleosomal safety, epigenetic setting, and gene expression within the cell sorts that contributed to cfDNA. Nevertheless, present progress on the event of computational strategies and understanding of molecular mechanisms behind cfDNA fragmentation patterns is considerably restricted by the controlled-access of cfDNA whole-genome sequencing (WGS) dataset.
Right here, we current FinaleDB (FragmentatIoN AnaLysis of cEll-free DNA DataBase), a complete database to host hundreds of uniformly processed and curated de-identified cfDNA WGS datasets throughout totally different pathological situations.
Moreover, FinaleDB comes with a fragmentation genome browser, from which customers can seamlessly combine hundreds of different omics knowledge in numerous cell sorts to expertise a complete view of each gene-regulatory panorama and cfDNA fragmentation patterns.
RhizoBindingSites, a Database of DNA-Binding Motifs in Nitrogen-Fixing Micro organism Inferred Utilizing a Footprint Discovery Method
Primary information of transcriptional regulation is required to know the mechanisms governing organic processes, i.e., nitrogen fixation by Rhizobiales micro organism in symbiosis with leguminous crops.
The RhizoBindingSites database is a computer-assisted framework offering motif-gene-associated conserved sequences doubtlessly implicated in transcriptional regulation in 9 symbiotic species. A dyad evaluation algorithm was used to deduce motifs within the upstream regulatory area of orthologous genes, and solely motifs additionally positioned within the gene seed promoter with a p-value of 1e-Four had been accepted.
A genomic scan evaluation of the upstoream sequences with these motifs was carried out. These predicted binding websites had been categorized in keeping with low, medium and excessive homology between the matrix and the upstream regulatory sequence. On common, 62.7% of the genes had a motif, accounting for 80.44% of the genes per genome, with 19613 matrices (a matrix is a illustration of a motif).
The RhizoBindingSites database supplies motif and gene info, motif conservation within the order Rhizobiales, matrices, motif logos, regulatory networks constructed from theoretical or experimental knowledge, a criterion for choosing motifs and a information for customers.
Fluorescent Lactic Acid Micro organism and Bifidobacteria as Autos of DNA Microbial Biosensors
Administration and quantification of effector molecules comparable to heavy metals, toxins or totally different purpose molecules is of good biotechnological, social and monetary curiosity. Microorganisms have regulatory proteins that acknowledge and modify the gene expression throughout the presence or absence of these compounds (effector molecules) through binding to gene sequences. The affiliation of these recognizing gene sequences to reporter genes will allow the detection of effector molecules of curiosity with extreme sensitivity.
As quickly as investigators have these two elements-recognizing gene sequences and reporter genes that emit signals-we need an applicable car to introduce every parts. Proper right here, we suggest lactic acid micro organism (LAB) and bifidobacteria as promising service microorganisms for these molecular biosensors. Utilizing fluorescent proteins along with food-grade vectors and clustered repeatedly interspaced transient palindromic repeats (CRISPR) are indispensable devices for introducing biosensors into these microorganisms. Utilizing these LAB and bifidobacteria could be of specific curiosity for studying the intestinal setting or totally different superior ecosystems.
The nice variety of species tailor-made to many environments, along with the chance of creating use of quite a lot of protocols for his or her transformation with recognizing gene sequences and reporter genes are considerable advantages. Lastly, an effort needs to be made to look out recognizable gene sequences.

DNAAF5 Antibody |
|||
| MBS968946-005mg | MyBiosource | 0.05mg | EUR 190 |
DNAAF5 Antibody |
|||
| MBS968946-01mg | MyBiosource | 0.1mg | EUR 270 |
DNAAF5 Antibody |
|||
| MBS968946-5x01mg | MyBiosource | 5x0.1mg | EUR 1205 |
DNAAF5 Antibody |
|||
| MBS9416165-01mL | MyBiosource | 0.1mL | EUR 305 |
DNAAF5 Antibody |
|||
| MBS9416165-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
DNAAF5 Antibody (HRP) |
|||
| abx308300-100g | Abbexa | 100 µg | EUR 362.5 |
DNAAF5 Antibody (HRP) |
|||
| 20-abx308300 | Abbexa |
|
|
DNAAF5 Antibody (HRP) |
|||
| abx308300-20g | Abbexa | 20 µg | EUR 162.5 |
DNAAF5 Antibody (HRP) |
|||
| abx308300-50g | Abbexa | 50 µg | EUR 250 |
DNAAF5 Antibody (FITC) |
|||
| abx308301-100g | Abbexa | 100 µg | EUR 362.5 |
DNAAF5 Antibody (FITC) |
|||
| 20-abx308301 | Abbexa |
|
|
DNAAF5 Antibody (FITC) |
|||
| abx308301-20g | Abbexa | 20 µg | EUR 162.5 |
DNAAF5 Antibody (FITC) |
|||
| abx308301-50g | Abbexa | 50 µg | EUR 250 |
DNAAF5 Antibody (Biotin) |
|||
| abx308302-100g | Abbexa | 100 µg | EUR 362.5 |
DNAAF5 Antibody (Biotin) |
|||
| 20-abx308302 | Abbexa |
|
|
DNAAF5 Antibody (Biotin) |
|||
| abx308302-20g | Abbexa | 20 µg | EUR 162.5 |
DNAAF5 Antibody (Biotin) |
|||
| abx308302-50g | Abbexa | 50 µg | EUR 250 |
DNAAF5 Polyclonal Antibody |
|||
| A58814 | EpiGentek |
|
|
DNAAF5 Conjugated Antibody |
|||
| C42981 | SAB | 100ul | EUR 476.4 |
DNAAF5 Polyclonal Antibody |
|||
| MBS2562240-002mL | MyBiosource | 0.02mL | EUR 140 |
DNAAF5 Polyclonal Antibody |
|||
| MBS2562240-006mL | MyBiosource | 0.06mL | EUR 180 |
DNAAF5 Polyclonal Antibody |
|||
| MBS2562240-012mL | MyBiosource | 0.12mL | EUR 260 |
DNAAF5 Polyclonal Antibody |
|||
| MBS2562240-02mL | MyBiosource | 0.2mL | EUR 405 |
DNAAF5 Polyclonal Antibody |
|||
| MBS2562240-5x02mL | MyBiosource | 5x0.2mL | EUR 1725 |
DNAAF5 Conjugated Antibody |
|||
| MBS9451313-01mLAF350 | MyBiosource | 0.1mL(AF350) | EUR 480 |
DNAAF5 Conjugated Antibody |
|||
| MBS9451313-01mLAF405 | MyBiosource | 0.1mL(AF405) | EUR 480 |
DNAAF5 Conjugated Antibody |
|||
| MBS9451313-01mLAF488 | MyBiosource | 0.1mL(AF488) | EUR 480 |
DNAAF5 Conjugated Antibody |
|||
| MBS9451313-01mLAF555 | MyBiosource | 0.1mL(AF555) | EUR 480 |
DNAAF5 Conjugated Antibody |
|||
| MBS9451313-01mLBiotin | MyBiosource | 0.1mL(Biotin) | EUR 480 |
DNAAF5 Antibody, HRP conjugated |
|||
| 1-CSB-PA771471LB01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against DNAAF5. Recognizes DNAAF5 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
DNAAF5 Antibody, HRP conjugated |
|||
| MBS1492279-005mg | MyBiosource | 0.05mg | EUR 190 |
DNAAF5 Antibody, HRP conjugated |
|||
| MBS1492279-01mg | MyBiosource | 0.1mg | EUR 270 |
DNAAF5 Antibody, HRP conjugated |
|||
| MBS1492279-5x01mg | MyBiosource | 5x0.1mg | EUR 1205 |
DNAAF5 Antibody, FITC conjugated |
|||
| 1-CSB-PA771471LC01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against DNAAF5. Recognizes DNAAF5 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
DNAAF5 Antibody, FITC conjugated |
|||
| MBS1499405-005mg | MyBiosource | 0.05mg | EUR 190 |
DNAAF5 Antibody, FITC conjugated |
|||
| MBS1499405-01mg | MyBiosource | 0.1mg | EUR 270 |
DNAAF5 Antibody, FITC conjugated |
|||
| MBS1499405-5x01mg | MyBiosource | 5x0.1mg | EUR 1205 |
DNAAF5 Antibody, Biotin conjugated |
|||
| 1-CSB-PA771471LD01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against DNAAF5. Recognizes DNAAF5 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
|||
DNAAF5 Antibody, Biotin conjugated |
|||
| MBS1498299-005mg | MyBiosource | 0.05mg | EUR 190 |
DNAAF5 Antibody, Biotin conjugated |
|||
| MBS1498299-01mg | MyBiosource | 0.1mg | EUR 270 |
DNAAF5 Antibody, Biotin conjugated |
|||
| MBS1498299-5x01mg | MyBiosource | 5x0.1mg | EUR 1205 |
OAGA06580-100UL - DNAAF5 Antibody |
|||
| OAGA06580-100UL | Aviva Systems Biology | 100ul | EUR 369 |
DNAAF5 Rabbit Polyclonal Antibody |
|||
| E10G02198 | EnoGene | 100 μl | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
DNAAF5 Polyclonal Antibody, HRP Conjugated |
|||
| A58817 | EpiGentek |
|
|
DNAAF5 Polyclonal Antibody, FITC Conjugated |
|||
| A58816 | EpiGentek |
|
|
DNAAF5 Polyclonal Antibody, Biotin Conjugated |
|||
| A58815 | EpiGentek |
|
|
Recombinant Human DNAAF5 Protein |
|||
| E30P65944B | EnoGene | 50 ug | EUR 295 |
Mouse Dnaaf5 qPCR Primer Pair |
|||
| QM74890S | Beyotime Biotech Inc | 200 Tests | Ask for price |
Human DNAAF5 qPCR Primer Pair |
|||
| QH43485S | Beyotime Biotech Inc | 200 Tests | Ask for price |
Dnaaf5 (Rat) - 3 unique 27mer siRNA duplexes - 2 nmol each |
|||
| SR513187 | Origene Technologies GmbH | 2 nmol | Ask for price |
DNAAF5 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each |
|||
| SR310343 | Origene Technologies GmbH | 2 nmol | Ask for price |
Dnaaf5 (Mouse) - 3 unique 27mer siRNA duplexes - 2 nmol each |
|||
| SR420710 | Origene Technologies GmbH | 2 nmol | Ask for price |
Human Dynein Assembly Factor 5, Axonemal / HEATR2 (DNAAF5) ELISA Kit |
|||
| abx387761-96tests | Abbexa | 96 tests | EUR 687.5 |
Dnaaf5 - Rat, 4 unique 29mer shRNA constructs in lentiviral GFP vector |
|||
| TL708859 | Origene Technologies GmbH | 5 µg/vial | Ask for price |
Dnaaf5 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector |
|||
| TL518008 | Origene Technologies GmbH | 5 µg/vial | Ask for price |
DNAAF5 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector |
|||
| TL304136 | Origene Technologies GmbH | 5 µg/vial | Ask for price |
Dnaaf5 - Rat, 4 unique 29mer shRNA constructs in retroviral untagged vectorr |
|||
| TR708859 | Origene Technologies GmbH | 5 µg/vial | Ask for price |
DNAAF5 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector |
|||
| TR304136 | Origene Technologies GmbH | 5 µg/vial | Ask for price |
dnaaf10 Antibody |
|||
| CSB-PA687921XA01DIL-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Danio rerio (Zebrafish) (Brachydanio rerio) dnaaf10 protein |
|||
dnaaf10 Antibody |
|||
| CSB-PA687921XA01DIL-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Danio rerio (Zebrafish) (Brachydanio rerio) dnaaf10 protein |
|||
dnaaf11 Antibody |
|||
| CSB-PA453211XA01DIL-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Danio rerio (Zebrafish) (Brachydanio rerio) dnaaf11 protein |
|||
dnaaf11 Antibody |
|||
| CSB-PA453211XA01DIL-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Danio rerio (Zebrafish) (Brachydanio rerio) dnaaf11 protein |
|||
dnaaf10 Antibody |
|||
| MBS7194920-INQUIRE | MyBiosource | INQUIRE | Ask for price |
dnaaf11 Antibody |
|||
| MBS7170603-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Dnaaf5 - Mouse, 4 unique 29mer shRNA constructs in retroviral untagged vectorr |
|||
| TR518008 | Origene Technologies GmbH | 5 µg/vial | Ask for price |
DNAAF3 Antibody |
|||
| 1-CSB-PA850845LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against DNAAF3. Recognizes DNAAF3 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200 |
|||
DNAAF4 Antibody |
|||
| 1-CSB-PA855504LA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against DNAAF4. Recognizes DNAAF4 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF; Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200, IF:1:50-1:200 |
|||
dnaaf2 Antibody |
|||
| CSB-PA672096XA01DIL-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Danio rerio (Zebrafish) (Brachydanio rerio) dnaaf2 protein |
|||
dnaaf2 Antibody |
|||
| CSB-PA672096XA01DIL-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Danio rerio (Zebrafish) (Brachydanio rerio) dnaaf2 protein |
|||
dnaaf3 Antibody |
|||
| CSB-PA520520XA01DIL-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Danio rerio (Zebrafish) (Brachydanio rerio) dnaaf3 protein |
|||
dnaaf3 Antibody |
|||
| CSB-PA520520XA01DIL-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Danio rerio (Zebrafish) (Brachydanio rerio) dnaaf3 protein |
|||
DNAAF1 Antibody |
|||
| DF14672 | Affbiotech | 100ul | EUR 420 |
DNAAF1 Antibody |
|||
| DF14672-100ul | Affinity Biosciences | 100ul | EUR 168 |
|
Description: ELISA(peptide) |
|||
DNAAF1 Antibody |
|||
| DF14672-200ul | Affinity Biosciences | 200ul | EUR 210 |
|
Description: ELISA(peptide) |
|||
dnaaf1 Antibody |
|||
| CSB-PA773627XA01DIL-02mg | Cusabio | 0.2mg | Ask for price |
|
Description: Recombinant Danio rerio (Zebrafish) (Brachydanio rerio) dnaaf1 protein |
|||
dnaaf1 Antibody |
|||
| CSB-PA773627XA01DIL-10mg | Cusabio | 10mg | Ask for price |
|
Description: Recombinant Danio rerio (Zebrafish) (Brachydanio rerio) dnaaf1 protein |
|||
DNAAF3 Antibody |
|||
| abx313748-100g | Abbexa | 100 µg | EUR 362.5 |
DNAAF3 Antibody |
|||
| 20-abx313748 | Abbexa |
|
|
DNAAF3 Antibody |
|||
| abx313748-20g | Abbexa | 20 µg | EUR 162.5 |
DNAAF3 Antibody |
|||
| abx313748-50g | Abbexa | 50 µg | EUR 250 |
DNAAF2 Antibody |
|||
| E40PV8515 | EnoGene | 50ul | EUR 395 |
|
Description: Available in various conjugation types. |
|||
DNAAF3 Antibody |
|||
| MBS7043984-005mg | MyBiosource | 0.05mg | EUR 190 |
DNAAF3 Antibody |
|||
| MBS7043984-01mg | MyBiosource | 0.1mg | EUR 270 |
DNAAF3 Antibody |
|||
| MBS7043984-5x01mg | MyBiosource | 5x0.1mg | EUR 1205 |
DNAAF1 Antibody |
|||
| MBS9632343-1mg | MyBiosource | 1mg | EUR 375 |
DNAAF1 Antibody |
|||
| MBS9632343-5x1mg | MyBiosource | 5x1mg | EUR 1545 |
DNAAF1 Antibody |
|||
| MBS9629960-01mL | MyBiosource | 0.1mL | EUR 260 |
DNAAF1 Antibody |
|||
| MBS9629960-02mL | MyBiosource | 0.2mL | EUR 305 |
DNAAF1 Antibody |
|||
| MBS9629960-5x02mL | MyBiosource | 5x0.2mL | EUR 1220 |
DNAAF1 antibody |
|||
| MBS832324-01mL | MyBiosource | 0.1mL | EUR 1095 |
DNAAF1 antibody |
|||
| MBS832324-5x01mL | MyBiosource | 5x0.1mL | EUR 4770 |
DNAAF1 antibody |
|||
| MBS832877-01mL | MyBiosource | 0.1mL | EUR 1095 |
DNAAF1 antibody |
|||
| MBS832877-5x01mL | MyBiosource | 5x0.1mL | EUR 4770 |
DNAAF1 antibody |
|||
| MBS833645-01mL | MyBiosource | 0.1mL | EUR 1095 |
DNAAF1 antibody |
|||
| MBS833645-5x01mL | MyBiosource | 5x0.1mL | EUR 4770 |
DNAAF1 antibody |
|||
| 10R-6893 | Fitzgerald Industries International | 100 ul | Ask for price |
DNAAF1 antibody |
|||
| 10R-6892 | Fitzgerald Industries International | 100 ul | Ask for price |
DNAAF1 antibody |
|||
| 10R-6890 | Fitzgerald Industries International | 100 ul | Ask for price |
DNAAF3 Antibody (HRP) |
|||
| abx313749-100g | Abbexa | 100 µg | EUR 362.5 |
DNAAF3 Antibody (HRP) |
|||
| 20-abx313749 | Abbexa |
|
|
DNAAF3 Antibody (HRP) |
|||
| abx313749-20g | Abbexa | 20 µg | EUR 162.5 |
DNAAF3 Antibody (HRP) |
|||
| abx313749-50g | Abbexa | 50 µg | EUR 250 |
DNAAF3 Antibody (FITC) |
|||
| abx313750-100g | Abbexa | 100 µg | EUR 362.5 |
DNAAF3 Antibody (FITC) |
|||
| 20-abx313750 | Abbexa |
|
|
DNAAF3 Antibody (FITC) |
|||
| abx313750-20g | Abbexa | 20 µg | EUR 162.5 |
DNAAF3 Antibody (FITC) |
|||
| abx313750-50g | Abbexa | 50 µg | EUR 250 |
DNAAF3 Antibody (Biotin) |
|||
| abx313751-100g | Abbexa | 100 µg | EUR 362.5 |
DNAAF3 Antibody (Biotin) |
|||
| 20-abx313751 | Abbexa |
|
|
DNAAF3 Antibody (Biotin) |
|||
| abx313751-20g | Abbexa | 20 µg | EUR 162.5 |
DNAAF3 Antibody (Biotin) |
|||
| abx313751-50g | Abbexa | 50 µg | EUR 250 |
DNAAF3 Antibody - middle region |
|||
| MBS3200084-01mL | MyBiosource | 0.1mL | EUR 455 |
DNAAF3 Antibody - middle region |
|||
| MBS3200084-5x01mL | MyBiosource | 5x0.1mL | EUR 1995 |
DNAAF1 Antibody - middle region |
|||
| MBS3220142-01mL | MyBiosource | 0.1mL | EUR 455 |
DNAAF1 Antibody - middle region |
|||
| MBS3220142-5x01mL | MyBiosource | 5x0.1mL | EUR 1995 |
DNAAF4 Antibody - middle region |
|||
| MBS3210845-01mL | MyBiosource | 0.1mL | EUR 455 |
DNAAF4 Antibody - middle region |
|||
| MBS3210845-5x01mL | MyBiosource | 5x0.1mL | EUR 1995 |
DNAAF3 Antibody, HRP conjugated |
|||
| 1-CSB-PA850845LB01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against DNAAF3. Recognizes DNAAF3 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
DNAAF4 Antibody, HRP conjugated |
|||
| 1-CSB-PA855504LB01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against DNAAF4. Recognizes DNAAF4 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
DNAAF3 Antibody, HRP conjugated |
|||
| MBS7044928-005mg | MyBiosource | 0.05mg | EUR 190 |
DNAAF3 Antibody, HRP conjugated |
|||
| MBS7044928-01mg | MyBiosource | 0.1mg | EUR 270 |
DNAAF3 Antibody, HRP conjugated |
|||
| MBS7044928-5x01mg | MyBiosource | 5x0.1mg | EUR 1205 |
DNAAF3 Antibody, FITC conjugated |
|||
| 1-CSB-PA850845LC01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against DNAAF3. Recognizes DNAAF3 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
DNAAF4 Antibody, FITC conjugated |
|||
| 1-CSB-PA855504LC01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against DNAAF4. Recognizes DNAAF4 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
DNAAF3 Antibody, FITC conjugated |
|||
| MBS7046368-005mg | MyBiosource | 0.05mg | EUR 190 |
DNAAF3 Antibody, FITC conjugated |
|||
| MBS7046368-01mg | MyBiosource | 0.1mg | EUR 270 |
DNAAF3 Antibody, FITC conjugated |
|||
| MBS7046368-5x01mg | MyBiosource | 5x0.1mg | EUR 1205 |
OACA09659-50UG - DNAAF3 Antibody |
|||
| OACA09659-50UG | Aviva Systems Biology | 50ug | EUR 179 |
DNAAF3 Antibody, Biotin conjugated |
|||
| 1-CSB-PA850845LD01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against DNAAF3. Recognizes DNAAF3 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
|||
DNAAF4 Antibody, Biotin conjugated |
|||
| 1-CSB-PA855504LD01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against DNAAF4. Recognizes DNAAF4 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
|||
DNAAF3 Antibody, Biotin conjugated |
|||
| MBS7044753-005mg | MyBiosource | 0.05mg | EUR 190 |
DNAAF3 Antibody, Biotin conjugated |
|||
| MBS7044753-01mg | MyBiosource | 0.1mg | EUR 270 |
DNAAF3 Antibody, Biotin conjugated |
|||
| MBS7044753-5x01mg | MyBiosource | 5x0.1mg | EUR 1205 |
OAGA05889-100UL - DNAAF4 Antibody |
|||
| OAGA05889-100UL | Aviva Systems Biology | 100ul | EUR 369 |
OACA09659-100UG - DNAAF3 Antibody |
|||
| OACA09659-100UG | Aviva Systems Biology | 100ug | EUR 319 |
DNAAF3 Antibody - C-terminal region |
|||
| MBS3218262-01mL | MyBiosource | 0.1mL | EUR 455 |
DNAAF3 Antibody - C-terminal region |
|||
| MBS3218262-5x01mL | MyBiosource | 5x0.1mL | EUR 1995 |
DNAAF3 Antibody - C-terminal region |
|||
| MBS3218263-01mL | MyBiosource | 0.1mL | EUR 455 |
DNAAF3 Antibody - C-terminal region |
|||
| MBS3218263-5x01mL | MyBiosource | 5x0.1mL | EUR 1995 |
DNAAF1 Antibody - N-terminal region |
|||
| MBS3220141-01mL | MyBiosource | 0.1mL | EUR 455 |
DNAAF1 Antibody - N-terminal region |
|||
| MBS3220141-5x01mL | MyBiosource | 5x0.1mL | EUR 1995 |
DNAAF4 Antibody - C-terminal region |
|||
| MBS3210844-01mL | MyBiosource | 0.1mL | EUR 455 |
DNAAF4 Antibody - C-terminal region |
|||
| MBS3210844-5x01mL | MyBiosource | 5x0.1mL | EUR 1995 |
DNAAF1 Polyclonal Antibody |
|||
| 29897 | SAB | 100ul | EUR 439 |
DNAAF1 Polyclonal Antibody |
|||
| 29897-100ul | SAB | 100ul | EUR 302.4 |
DNAAF1 Polyclonal Antibody |
|||
| 29897-50ul | SAB | 50ul | EUR 224.4 |
DNAAF1 Polyclonal Antibody |
|||
| E-AB-66867-120uL | Elabscience Biotech | 120uL | EUR 320 |
|
Description: Unconjugated |
|||
DNAAF1 Polyclonal Antibody |
|||
| E-AB-66867-200uL | Elabscience Biotech | 200uL | EUR 530 |
|
Description: Unconjugated |
|||
DNAAF1 Polyclonal Antibody |
|||
| E-AB-66867-60uL | Elabscience Biotech | 60uL | EUR 200 |
|
Description: Unconjugated |
|||
DNAAF1 Polyclonal Antibody |
|||
| E-AB-66867-each | Elabscience Biotech | each | Ask for price |
|
Description: Unconjugated |
|||
DNAAF1 polyclonal antibody |
|||
| BS76871 | Bioworld Biotech | 50ul | EUR 358 |
|
Description: 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2 |
|||
DNAAF1 Polyclonal Antibody |
|||
| E916593 | EnoGene | 100ul | EUR 225 |
|
Description: Available in various conjugation types. |
|||
DNAAF1 Polyclonal Antibody |
|||
| MBS2565699-006mL | MyBiosource | 0.06mL | EUR 190 |
DNAAF1 Polyclonal Antibody |
|||
| MBS2565699-012mL | MyBiosource | 0.12mL | EUR 265 |
DNAAF1 Polyclonal Antibody |
|||
| MBS2565699-02mL | MyBiosource | 0.2mL | EUR 415 |
DNAAF1 Polyclonal Antibody |
|||
| MBS2565699-5x02mL | MyBiosource | 5x0.2mL | EUR 1835 |
DNAAF1 Polyclonal Antibody |
|||
| MBS8571250-01mL | MyBiosource | 0.1mL | EUR 305 |
DNAAF1 Polyclonal Antibody |
|||
| MBS8571250-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
DNAAF1 Polyclonal Antibody |
|||
| MBS8571250-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
DNAAF1 Polyclonal Antibody |
|||
| MBS8571250-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
DNAAF1 Polyclonal Antibody |
|||
| MBS8571250-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
Irregular Homocysteine Metabolism: An Notion of Alzheimer’s Sickness from DNA Methylation
Alzheimer’s sickness (AD) is a persistent neurodegenerative sickness throughout the central nervous system that has superior pathogenesis throughout the aged. The current analysis focuses on the epigenetic mechanisms of AD, in response to the latest findings. The best-characterized chromatin modifications in epigenetic mechanisms is DNA methylation. Extraordinarily replicable information reveals that AD incidence is often accompanied by methylation diploma changes of the AD-related gene.
Homocysteine (Hcy) is simply not solely an intermediate product of one-carbon metabolism however as well as an important neutral hazard problem of AD; it might presumably impact the cognitive carry out of the thoughts by altering the one-carbon metabolism and interfering with the DNA methylation course of, resulting in cerebrovascular sickness. Normally, Hcy may be an environmental problem that impacts AD by means of the DNA methylation pathway with a set of changes in AD-related substance. This analysis will take into consideration the relation between DNA methylation and Hcy and check out to find out their rule throughout the pathophysiology of AD.
TET is focused for proteasomal degradation by the PHD-pVHL pathway to scale back DNA hydroxymethylation
Hypoxia-inducible parts are heterodimeric transcription parts that play an essential place in a cell’s functionality to adapt to low oxygen. The von-Hippel Lindau tumor suppressor (pVHL), acts as a grasp regulator of HIF train, and its specializing in of prolyl hydroxylated HIF-α for proteasomal degradation beneath normoxia is taken into account a big mechanism for pVHL tumor suppression and cellular response to oxygen.
Whether or not or not pVHL regulates totally different targets by the identical mechanism is actually unknown. Proper right here, we decide TET2/Three as novel targets of pVHL. pVHL induces proteasomal degradation of TET2/3, resulting in decreased worldwide 5-hydroxymethylcytosine ranges.
Conserved proline residues contained in the LAP/LAP-like motifs of these two proteins are hydroxylated by the prolyl hydroxylase enzymes (PHD2/EGLN1 and PHD3/EGLN3), which is prerequisite for pVHL-mediated degradation. Using zebrafish as a model, we determined that worldwide 5-hydroxymethylcytosine ranges are enhanced in vhl-null, egln1a/b-double null and egln3-null embryos.
Subsequently, we reveal a novel carry out for the PHD-pVHL pathway in regulating TET protein stability and train. These information lengthen our understanding of how TET proteins are regulated and provide new notion into the mechanisms of pVHL in tumor suppression.
Degree-of-care DNA testing by routinely and sequentially performing extraction, amplification and identification in a closed-type cassette
- Nucleic acid detection is significant for scientific diagnostics; nonetheless, it is troublesome to hold out genetic testing on the point-of-care due to the tedious steps involved in DNA extraction and the prospect of cross-contamination from amplicons.
- To comprehend a fully-automated and contamination-free nucleic acid detection, we advise a closed-type cassette system which permits the following steps to be operated routinely and sequentially: sample preparation based mostly totally on magnetic beads, purpose amplification using multiplex polymerase chain response, and colorimetric detection of amplicons using a serial invasive response coupled with the aggregation of gold nanoparticle probes.
- The cassette was designed to be spherical and closed, and 10 targets in a sample could be concurrently detected by the naked eye or using a spectrophotometer throughout the system.
- In addition to, a cassette-driven system was fabricated to change reagents between wells, to manage the temperature of each response, and to sense the colour throughout the detection wells. The cassette system was delicate ample to detect 10 genotypes at 5 single nucleotide polymorphism web sites related to the anticoagulant’s utilization, by way of using a 0.5 µL blood sample.
- The accuracy of the system was evaluated by detecting 12 total blood samples, and the outcomes obtained have been in keeping with these obtained using pyrosequencing. The cassette is airtight and your entire system is completely computerized; the one information operation is the addition of the sample to the cassette, performing point-of-care genetic testing in a sample-in/answer-out means.
